Actinium Pharmaceuticals, Inc. (ATNM)
1.15
0.00 (0.00%)
USD |
NYAM |
Feb 09, 16:00
1.11
-0.04
(-3.48%)
After-Hours: 20:00
Actinium Pharmaceuticals EPS Diluted (Quarterly) : -0.1645 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 1.612 |
| Altimmune, Inc. | -0.2126 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
| Avanos Medical, Inc. | -0.0302 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.131M |
| Revenue (Quarterly) | 0.09M |
| Total Expenses (Quarterly) | 5.221M |
| Enterprise Value | -16.37M |
| Gross Profit Margin (Quarterly) | -128.9% |
| Profit Margin (Quarterly) | -5.70K% |
| Earnings Yield | -96.44% |
| Normalized Earnings Yield | -96.44 |